Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics

Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease that affects over 30% of the world’s population. For decades, the heterogeneity of non-alcoholic fatty liver disease (NAFLD) has impeded our understanding of the disease mechanism...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao, Mingfeng Xia
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2024-04-01
Цуврал:	Lipids in Health and Disease
Нөхцлүүд:	Metabolic dysfunction-associated fatty liver disease Hepatic lipid metabolism Multisystem disease Pathophysiology Medications Clinical trials
Онлайн хандалт:	https://doi.org/10.1186/s12944-024-02092-2
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!